Keros Therapeutics, Inc. (NASDAQ:KROS) Receives $88.29 Consensus Target Price from Brokerages
Keros Therapeutics, Inc. (NASDAQ:KROS – Get Free Report) has received an average rating of “Buy” from the eight brokerages that are currently covering the firm, Marketbeat Ratings reports. Eight analysts have rated the stock with a buy rating. The average twelve-month price objective among analysts that have covered the stock in the last year is […]
More Stories
Analysts Set Outset Medical, Inc. (NASDAQ:OM) Price Target at $4.64
Shares of Outset Medical, Inc. (NASDAQ:OM – Get Free Report) have been given an average recommendation of “Hold” by the...
Columbia Banking System, Inc. (NASDAQ:COLB) Receives $25.42 Average Target Price from Brokerages
Shares of Columbia Banking System, Inc. (NASDAQ:COLB – Get Free Report) have earned an average rating of “Hold” from the...
Renasant Co. (NASDAQ:RNST) Receives Average Recommendation of “Moderate Buy” from Analysts
Shares of Renasant Co. (NASDAQ:RNST – Get Free Report) have been assigned an average rating of “Moderate Buy” from the...
Brokerages Set EnLink Midstream, LLC (NYSE:ENLC) Target Price at $15.33
EnLink Midstream, LLC (NYSE:ENLC – Get Free Report) has been given an average rating of “Hold” by the ten ratings...
Factory Orders Decline in August as Manufacturing Woes Deepen
By Tom Ozimek Factory orders unexpectedly fell in August, stoking concerns about the deepening downturn in the U.S. manufacturing sector....
Citigroup Increases Medtronic (NYSE:MDT) Price Target to $92.00
Medtronic (NYSE:MDT – Free Report) had its target price increased by Citigroup from $85.00 to $92.00 in a research note...